- Home
- TNGX vs CZFS Comparison
TNGX vs CZFS Comparison
Compare TNGX & CZFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- CZFS
- Stock Information
- Founded
- TNGX 2014
- CZFS 1984
- Country
- TNGX United States
- CZFS United States
- Employees
- TNGX N/A
- CZFS N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- CZFS Major Banks
- Sector
- TNGX Health Care
- CZFS Finance
- Exchange
- TNGX Nasdaq
- CZFS Nasdaq
- Market Cap
- TNGX 351.2M
- CZFS 291.1M
- IPO Year
- TNGX N/A
- CZFS N/A
- Fundamental
- Price
- TNGX $6.01
- CZFS $60.90
- Analyst Decision
- TNGX Strong Buy
- CZFS
- Analyst Count
- TNGX 6
- CZFS 0
- Target Price
- TNGX $12.20
- CZFS N/A
- AVG Volume (30 Days)
- TNGX 2.7M
- CZFS 9.9K
- Earning Date
- TNGX 08-06-2025
- CZFS 07-29-2025
- Dividend Yield
- TNGX N/A
- CZFS 3.08%
- EPS Growth
- TNGX N/A
- CZFS 53.00
- EPS
- TNGX N/A
- CZFS 5.91
- Revenue
- TNGX $40,990,000.00
- CZFS $99,929,000.00
- Revenue This Year
- TNGX N/A
- CZFS N/A
- Revenue Next Year
- TNGX N/A
- CZFS $5.45
- P/E Ratio
- TNGX N/A
- CZFS $10.77
- Revenue Growth
- TNGX 10.09
- CZFS 9.54
- 52 Week Low
- TNGX $1.03
- CZFS $41.20
- 52 Week High
- TNGX $12.02
- CZFS $75.40
- Technical
- Relative Strength Index (RSI)
- TNGX 76.36
- CZFS 51.05
- Support Level
- TNGX $5.34
- CZFS $62.80
- Resistance Level
- TNGX $6.40
- CZFS $65.00
- Average True Range (ATR)
- TNGX 0.50
- CZFS 1.28
- MACD
- TNGX -0.02
- CZFS 0.39
- Stochastic Oscillator
- TNGX 84.08
- CZFS 49.88
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
About CZFS Citizens Financial Services Inc.
Citizens Financial Services Inc is a Pennsylvania-chartered bank and trust company. The company through its banking subsidiary provides banking activities and services for individual, business, governmental and institutional customers. Its activities and services principally include checking, savings, and time deposit accounts; residential, commercial and agricultural real estate, commercial and industrial, state and political subdivision and consumer loans; and a variety of other specialized financial services. The Trust and Investment division of the Bank offers a full range of client investment, estate, mineral management, and retirement services.